Human Microbiome Market by Product (Prebiotic, Probiotic, Food, Medical Food, Drug), Application (Therapeutic), Disease (Infectious, Metabolic/Endocrine, Cancer, Blood, Neurological), Research Technology (Proteomics, Metabolomics)- Global Forecast to 2027

Human Microbiome Market by Product (Prebiotic, Probiotic, Food, Medical Food, Drug), Application (Therapeutic), Disease (Infectious, Metabolic/Endocrine, Cancer, Blood, Neurological), Research Technology (Proteomics, Metabolomics) - Global Forecast to 2027

“Increased focus on human microbiome therapy development to drive the growth of this market.”
The global human microbiome market is projected to reach USD 1,731 million in 2027 from 942 million in 2024, at CAGR of 22.5 % during the forecast period. Market growth is largely driven by the increasing focus on the development of human microbiome therapy. It has also become a validated target for drug development. The growing number of collaborations between market players is expected to offer a wide range of growth opportunities for market players during the forecast period. However, a lack of expertise and detailed research on the human microbiome is restraining the growth of this market.

“Prebiotics are expected to grow at the highest CAGR during the forecast period.”
Based on product, the human microbiome market is segmented into probiotics, prebiotics, foods, medical foods, diagnostic tests, and drugs. Of these, probiotics are expected to grow at the highest CAGR during the forecast period. The large share of this market segment can primarily be attributed to growing awareness about probiotics as a potential therapy and the credibility of health claims and safety of probiotics.

“The diagnostics segment is expected to grow at the highest CAGR during the forecast period.”
Based on application, the human microbiome market is segmented into therapeutics and diagnostics. The diagnostics segment is expected to grow at the highest CAGR in the forecast period. Advances in life science research on a wide number of diseases, technological innovations in human genome mapping, the emergence of omics technologies, and the increasing emphasis on improving the cost-effectiveness of healthcare and patient outcomes are some of the major factors driving the growth of this segment.

“The infectious diseases segment is expected to grow at the highest CAGR during the forecast period.”
The infectious disease segment is expected to account for the largest share of the global human microbiome market in 2024. This is due to increasing research in microbiome-based products and their use in treating infectious diseases. Many smaller companies are investing in research, and their major focus is on developing products targeting the microbiome modulators for infectious diseases, which accounts for 40-50 products that are currently in the pipeline.

“The genomics segment is expected to grow at the highest CAGR during the forecast period.”
On the basis of technology, the human microbiome research spending market is segmented into genomics, proteomics, and metabolomics. The genomics segment is expected to grow at the highest CAGR during the forecast period. The increasing number of projects funded by private and government bodies is a key driver for the genomics market. Newly emerging disciplines such as metagenomics help researchers to uncover what microorganisms are present in a sample, to determine their relative abundance and gain insights on their biochemical pathways.

“North America to grow at the highest CAGR during the forecast period.”
In the human microbiome market, North America is estimated to grow at the highest CAGR during the forecast period. Factors such as the increasing incidence of lifestyle diseases, rising awareness on preventive healthcare, availability of funding for microbiome research, and growing acceptance of probiotic products are the factors driving the North American human microbiome market.

In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the human microbiome market.

By Company Type: Tier 1: 40%, Tier 2: 30%, and Tier 3: 30%
By Designation: C-level Executives: 27%, Directors: 18%, and Others: 55%
By Region: North America: 50%, Europe: 20%, APAC: 15%, and RoW: 15%

The human microbiome market comprises major players such as Enterome Bioscience (France), Seres Therapeutics (US), and 4D Pharma (UK). The study includes an in-depth competitive analysis of these key players in the patient market, along with their company profiles, recent developments, and key market strategies.

Research Coverage:
The market study covers the human microbiome market across various segments. It aims at estimating the market size and the growth potential of this market across different segments, based on the product, application, disease, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information on the closest approximations of the revenue numbers for the overall human microbiome market and its subsegments. This report will help the stakeholders to understand the competitive landscape, to gain more insights to better position their businesses, and to plan suitable go-to-market strategies. The report will also help the stakeholders to understand the pulse of the market and provide information on key market drivers, restraints, opportunities, and challenges.


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS COVERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
      • SECONDARY SOURCES
      • PRIMARY SOURCES
    • MARKET SIZE ESTIMATION
    • MARKET BREAKDOWN AND DATA TRIANGULATION
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • HUMAN MICROBIOME: MARKET OVERVIEW
    • HUMAN MICROBIOME MARKET, BY PRODUCT
    • EUROPE: HUMAN MICROBIOME MARKET, BY PRODUCT & APPLICATION (2022)
    • HUMAN MICROBIOME MARKET, BY DISEASE
  • MARKET OVERVIEW
    • MARKET DYNAMICS
      • DRIVERS
      • RESTRAINTS
      • OPPORTUNITIES
      • CHALLENGES
  • HUMAN MICROBIOME MARKET, BY PRODUCT
    • INTRODUCTION
      • Table HUMAN MICROBIOME MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
    • PROBIOTICS
      • ONGOING RESEARCHES ON PROBIOTICS PROMOTING ITS CREDIBILITY IN HEALTH CLAIMS AND SAFETY
        • Table HUMAN MICROBIOME MARKET FOR PROBIOTICS, BY REGION, 2021-2027 (USD MILLION)
        • Table NORTH AMERICA: HUMAN MICROBIOME MARKET FOR PROBIOTICS, BY COUNTRY 2021-2027 (USD MILLION)
    • PREBIOTICS
      • DEVELOPMENT OF TARGETED PREBIOTICS TOWARDS ENHANCING GUT MICROBIOTA IS THE KEY GROWTH DRIVER FOR THIS SEGMENT
        • Table HUMAN MICROBIOME MARKET FOR PREBIOTICS, BY REGION, 2021-2027 (USD MILLION)
        • Table NORTH AMERICA: PREBIOTICS MARKET, BY COUNTRY 2021-2027 (USD MILLION)
    • FOODS
      • RISING AWARENESS OF MICROBIOTA-TARGETED DIETS IS DRIVING MARKET GROWTH
        • Table HUMAN MICROBIOME MARKET FOR FOODS, BY REGION, 2021-2027 (USD MILLION)
        • Table NORTH AMERICA: HUMAN MICROBIOME MARKET FOR FOODS, BY COUNTRY 2021-2027 (USD MILLION)
    • MEDICAL FOODS
      • USAGE OF TARGETED MICROBIOME FOR TREATING METABOLIC SYNDROME IS EXPECTED TO DRIVE THIS SEGMENT
        • Table HUMAN MICROBIOME MARKET FOR MEDICAL FOODS, BY REGION, 2021-2027 (USD MILLION)
        • Table NORTH AMERICA: HUMAN MICROBIOME MARKET FOR MEDICAL FOODS, BY COUNTRY 2021-2027 (USD MILLION)
    • DIAGNOSTIC TESTS
      • INCREASED CONSUMER AWARENESS ABOUT MICROBIOME-BASED TESTS, WHICH PROVIDE PREVENTATIVE HEALTH INSIGHTS TO DRIVE THIS SEGMENT
        • Table HUMAN MICROBIOME MARKET FOR DIAGNOSTIC TESTS, BY REGION, 2019-2027 (USD MILLION)
        • Table NORTH AMERICA: HUMAN MICROBIOME MARKET FOR DIAGNOSTIC TESTS, BY COUNTRY 2019-2027 (USD MILLION)
    • DRUGS
      • INCREASING NUMBER OF MICROBIOME-BASED DRUG PIPELINE IS THE KEY FACTOR DRIVING THE GROWTH OF THIS SEGMENT
        • Table HUMAN MICROBIOME MARKET FOR DRUGS, BY REGION, 2021-2027 (USD MILLION)
        • Table NORTH AMERICA: HUMAN MICROBIOME MARKET FOR DRUGS, BY COUNTRY 2021-2027 (USD MILLION)
  • HUMAN MICROBIOME MARKET, BY APPLICATION
    • INTRODUCTION
      • Table HUMAN MICROBIOME MARKET, BY APPLICATION, 2019-2027 (USD MILLION)
    • THERAPEUTICS
      • AVAILABILITY OF FUNDING FOR RESEARCH AND GROWING EVIDENCE FOR EFFECTIVENESS OF MICROBIOME IS FAVORING MARKET GROWTH
        • Table HUMAN MICROBIOME MARKET FOR THERAPEUTICS, BY REGION, 2019-2027 (USD MILLION)
        • Table NORTH AMERICA: HUMAN MICROBIOME MARKET FOR THERAPEUTICS, BY COUNTRY, 2019-2027 (USD MILLION)
    • DIAGNOSTICS
      • INCREASING FOCUS OF BIOTECH COMPANIES ON LIFE SCIENCE RESEARCH IS SUPPORTING MARKET GROWTH
        • Table HUMAN MICROBIOME MARKET FOR DIAGNOSTICS, BY REGION, 2019-2027 (USD MILLION)
        • Table NORTH AMERICA: HUMAN MICROBIOME MARKET FOR DIAGNOSTICS, BY COUNTRY, 2019-2027 (USD MILLION)
  • HUMAN MICROBIOME MARKET, BY DISEASE
    • INTRODUCTION
      • Table HUMAN MICROBIOME MARKET, BY DISEASE, 2019-2027 (USD MILLION)
    • INFECTIOUS DISEASES
      • INCREASING R&D INTO TARGETED ANTI-BACTERIAL PRODUCTS WILL DRIVE MARKET GROWTH
        • Table DEVELOPMENT OF MICROBIOME-BASED ANTI-BACTERIAL DRUGS FOR INFECTIOUS DISEASES
        • Table HUMAN MICROBIOME MARKET FOR INFECTIOUS DISEASES, BY REGION, 2019-2027 (USD MILLION)
        • Table NORTH AMERICA: HUMAN MICROBIOME MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
    • INFLAMMATORY DISEASES
      • SIDE-EFFECTS OF IMMUNOSUPPRESSANT'S HAVE PROMPTED DEMAND FOR BETTER THERAPEUTICS
        • Table DEVELOPMENT OF MICROBIOME-BASED PRODUCTS FOR INFLAMMATORY DISEASES
        • Table HUMAN MICROBIOME MARKET FOR INFLAMMATORY DISEASES, BY REGION, 2019-2027 (USD MILLION)
        • Table NORTH AMERICA: HUMAN MICROBIOME MARKET FOR INFLAMMATORY DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
    • ENDOCRINE & METABOLIC DISORDERS
      • GUT MICROBIOTA HAS BECOME A POTENTIAL NUTRITIONAL AND PHARMACOLOGICAL TARGET FOR OBESITY MANAGEMENT
        • Table DEVELOPMENT OF MICROBIOME-BASED PRODUCTS FOR METABOLIC DISEASES
        • Table HUMAN MICROBIOME MARKET FOR ENDOCRINE & METABOLIC DISORDERS, BY REGION, 2019-2027 (USD MILLION)
        • Table NORTH AMERICA: HUMAN MICROBIOME MARKET FOR ENDOCRINE & METABOLIC DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
    • CANCER
      • MICROBIOME-BASED PRODUCTS HAVE DEMONSTRATED EFFICACY IN THE TREATMENT OF CANCER POLYPS
        • Table HUMAN MICROBIOME MARKET FOR CANCER, BY REGION, 2019-2027 (USD MILLION)
        • Table NORTH AMERICA: HUMAN MICROBIOME MARKET FOR CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
    • OTHER DISEASES
      • Table HUMAN MICROBIOME MARKET FOR OTHER DISEASES, BY REGION, 2019-2027 (USD MILLION)
      • Table NORTH AMERICA: HUMAN MICROBIOME MARKET FOR OTHER DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
  • HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY TECHNOLOGY
    • INTRODUCTION
      • Table HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
    • GENOMICS
      • Table HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR GENOMICS, BY REGION, 2017-2024 (USD MILLION)
      • Table NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR GENOMICS, BY COUNTRY, 2017-2024 (USD MILLION)
      • Table HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR GENOMICS, BY TYPE, 2017-2024 (USD MILLION)
      • SEQUENCING
        • Table HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR SEQUENCING, BY METHOD, 2017-2024 (USD MILLION)
        • Table HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR SEQUENCING, BY REGION, 2017-2024 (USD MILLION)
        • Table NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR SEQUENCING, BY COUNTRY, 2017-2024 (USD MILLION)
      • OTHER GENOMICS TECHNOLOGIES
        • Table HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR OTHER GENOMICS TECHNOLOGIES, BY REGION, 2017-2024 (USD MILLION)
        • Table NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR OTHER GENOMICS TECHNOLOGIES, BY COUNTRY, 2017-2024 (USD MILLION)
    • PROTEOMICS
      • TECHNOLOGICAL ADVANCEMENTS IN PROTEOMICS TECHNOLOGIES TO DRIVE MARKET GROWTH
        • Table HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR PROTEOMICS, BY REGION, 2017-2024 (USD MILLION)
        • Table NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR PROTEOMICS, BY COUNTRY, 2017-2024 (USD MILLION)
    • METABOLOMICS
      • METABOLOMICS HAS SEVERAL ADVANTAGES OVER GENOMICS AND PROTEOMICS IN MICROBIOME RESEARCH
        • Table HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR METABOLOMICS, BY REGION, 2017-2024 (USD MILLION)
        • Table NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR METABOLOMICS, BY COUNTRY, 2017-2024 (USD MILLION)
  • HUMAN MICROBIOME MARKET, BY REGION
    • INTRODUCTION
      • Table HUMAN MICROBIOME MARKET, BY REGION, 2019-2027 (USD MILLION)
      • Table HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY REGION, 2017-2024 (USD MILLION)
    • EUROPE
      • EXTENDED APPLICATIONS FOR MICROBIOME TO THERAPEUTIC AREAS TO BOOST THE ADOPTION OF MICROBIOME-BASED PRODUCTS IN EUROPE
        • Table EUROPE: HUMAN MICROBIOME MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
        • Table EUROPE: HUMAN MICROBIOME MARKET, BY APPLICATION, 2019-2027 (USD MILLION)
        • Table EUROPE: HUMAN MICROBIOME MARKET, BY DISEASE, 2019-2027 (USD MILLION)
        • Table EUROPE: HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
        • Table EUROPE: HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR GENOMICS, BY TYPE, 2017-2024 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: HUMAN MICROBIOME MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
      • Table NORTH AMERICA: HUMAN MICROBIOME MARKET, BY APPLICATION, 2019-2027 (USD MILLION)
      • Table NORTH AMERICA: HUMAN MICROBIOME MARKET, BY DISEASE, 2019-2027 (USD MILLION)
      • Table NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
      • Table NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR GENOMICS, BY TYPE, 2014-2021 (USD MILLION)
      • US
        • Table US: HUMAN MICROBIOME MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
        • Table US: HUMAN MICROBIOME MARKET, BY APPLICATION, 2019-2027 (USD MILLION)
        • Table US: HUMAN MICROBIOME MARKET, BY DISEASE, 2019-2027 (USD MILLION)
        • Table US: HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
        • Table US: HUMAN MICROBIOME RESEARCH SPENDING FOR GENOMICS, BY TYPE, 2014-2021 (USD MILLION)
      • CANADA
        • Table INDICATIVE LIST OF PROJECTS ON HUMAN MICROBIOME IN 2018
        • Table CANADA: HUMAN MICROBIOME MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
        • Table CANADA: HUMAN MICROBIOME MARKET, BY APPLICATION, 2019-2027 (USD MILLION)
        • Table CANADA: HUMAN MICROBIOME MARKET, BY DISEASE, 2019-2027 (USD MILLION)
        • Table CANADA: HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
        • Table CANADA: HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR GENOMICS, BY TYPE, 2014-2021 (USD MILLION)
    • ASIA PACIFIC
      • INCREASING FOCUS ON MICROBIOME RESEARCH TO DRIVE MARKET GROWTH
        • Table ASIA PACIFIC: HUMAN MICROBIOME MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
        • Table ASIA PACIFIC: HUMAN MICROBIOME MARKET, BY APPLICATION, 2019-2027 (USD MILLION)
        • Table ASIA PACIFIC: HUMAN MICROBIOME MARKET, BY DISEASE, 2019-2027 (USD MILLION)
        • Table ASIA PACIFIC: HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
        • Table ASIA PACIFIC: HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR GENOMICS, BY TYPE, 2014-2021 (USD MILLION)
    • REST OF THE WORLD (ROW)
      • INCREASING INCIDENCE OF CANCER TO DRIVE THE DEVELOPMENT OF MICROBIOME-BASED DIAGNOSTIC TOOLS IN ROW
        • Table ROW: HUMAN MICROBIOME MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
        • Table ROW: HUMAN MICROBIOME MARKET, BY APPLICATION, 2019-2027 (USD MILLION)
        • Table ROW: HUMAN MICROBIOME MARKET, BY DISEASE, 2019-2027 (USD MILLION)
        • Table ROW: HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
        • Table ROW: HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR GENOMICS, BY TYPE, 2014-2021 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • COMPETITIVE LEADERSHIP MAPPING (2018)
      • INNOVATORS
      • EMERGING COMPANIES
    • COMPETITIVE SITUATION AND TRENDS
      • AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
        • Table AGREEMENTS AND PARTNERSHIPS, 2016-2019
      • ACQUISITIONS AND MERGERS
        • Table ACQUISITIONS AND MERGERS 2016-2019
      • PRODUCT LAUNCHES
        • Table PRODUCT LAUNCHES, 2016-2019
      • EXPANSIONS
        • Table EXPANSIONS, 2016-2019
  • COMPANY PROFILES
    • ENTEROME BIOSCIENCE
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • SERES THERAPEUTICS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • 4D PHARMA PLC
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • UBIOME, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • E.I. DU PONT DE NEMOURS AND COMPANY
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • SYNLOGIC
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • SECOND GENOME
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • VEDANTA BIOSCIENCES, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • FERRING PHARMACEUTICALS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • EVELO BIOSCIENCES, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • VITHERA PHARMACEUTICALS, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • BIOMX
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • LNC THERAPEUTICS
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
      • RECENT DEVELOPMENTS
  • APPENDIX
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook